Immuneering (IMRX) Non Operating Income (2021 - 2026)

Immuneering's Non Operating Income history runs 6 years deep, the most recent figure standing at $513735.0 for Q1 2026.

• In Q1 2026, Non Operating Income changed N/A year-over-year to $513735.0; the TTM figure through Mar 2026 stood at $825400.0 (up 261.29% YoY), while the FY2025 annual figure was $311665.0, down 29.41% from the prior year.
• Non Operating Income was $513735.0 for Q1 2026 at Immuneering, up from $311665.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $513735.0 in Q1 2026 to a low of -$103218.0 in Q1 2022.
• Historically, Non Operating Income has averaged $201286.1 across 5 years, with a median of $181615.0 in 2023.
• The sharpest annual moves came in 2022 and 2024: Non Operating Income surged 1593.82% in 2022, then slumped 94.86% in 2024.
• A 5-year view of Non Operating Income shows it stood at $223278.0 in 2022, then surged by 107.97% to $464352.0 in 2023, then plunged by 80.31% to $91430.0 in 2024, then soared by 240.88% to $311665.0 in 2025, then jumped by 64.84% to $513735.0 in 2026.
• The last three Non Operating Income figures came in at $513735.0 (Q1 2026), $311665.0 (Q4 2025), and $91430.0 (Q4 2024), per Business Quant data.